75.84
전일 마감가:
$73.54
열려 있는:
$74.09
하루 거래량:
7.32M
Relative Volume:
0.99
시가총액:
$31.34B
수익:
$9.51B
순이익/손실:
$2.64B
주가수익비율:
12.56
EPS:
6.0361
순현금흐름:
$2.14B
1주 성능:
-1.85%
1개월 성능:
+0.60%
6개월 성능:
-40.12%
1년 성능:
-50.25%
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ZTS
Zoetis Inc
|
75.84 | 30.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.39 | 55.60B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.80 | 43.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.52 | 42.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
UTHR
United Therapeutics Corp
|
501.27 | 21.95B | 3.17B | 1.29B | 1.01B | 27.09 |
조에티스 Stock (ZTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-12 | 재확인 | Stifel | Buy |
| 2023-12-19 | 재개 | Jefferies | Buy |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 개시 | Atlantic Equities | Overweight |
| 2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
| 2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-09-09 | 개시 | Goldman | Buy |
| 2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-08-03 | 재확인 | Stifel | Buy |
| 2018-04-19 | 재확인 | Citigroup | Buy |
| 2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 재확인 | Stifel | Buy |
| 2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies - Business Wire
Zoetis Inc. (ZTS) Stock Forecasts - Yahoo Finance
Zoetis gets US FDA emergency use nod for treatment for screwworm in dogs - Reuters
Handelsbanken Fonder AB Purchases 21,990 Shares of Zoetis Inc. $ZTS - MarketBeat
The Top 5 Analyst Questions From Zoetis’s Q2 Earnings Call - StockStory
Zoetis Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zoetis slides as investors remain focused on softer pet-care demand and competitive pressure - Quiver Quantitative
Zoetis (NYSE:ZTS) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
Zoetis Inc. (NYSE:ZTS) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Citigroup Lowers Zoetis (NYSE:ZTS) Price Target to $96.00 - MarketBeat
BNP Paribas Exane Issues Pessimistic Forecast for Zoetis (NYSE:ZTS) Stock Price - MarketBeat
ZOETIS INC : BNP PARIBAS CUTS TARGET PRICE TO $110 FROM $146 - Bitget
ZOETIS INC : CITIGROUP CUTS TARGET PRICE TO $96 FROM $112 - Bitget
Citigroup Adjusts Price Target on Zoetis to $96 From $112, Maintains Buy Rating - marketscreener.com
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Michael Burry Refreshes Bearish Palantir Trade Even As AI Rally Strains Short Bets - TradingView
Zoetis Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
Zoetis (NYSE:ZTS) Hits New 52-Week Low Following Analyst Downgrade - MarketBeat
BNP Paribas Adjusts Price Target on Zoetis to $110 From $146, Maintains Outperform Rating - marketscreener.com
Zoetis (ZTS) Looked Like a Winner. What Went Wrong? - Yahoo Finance
5 Stock Picks Last Week From Wall Street's Most Accurate Analysts - Benzinga
Zoetis Inc. (ZTS) Investor Outlook: Analyzing a Potential 43% Upside in the Healthcare Sector - DirectorsTalk Interviews
Zoetis (ZTS) Is Down 5.8% After Cutting 2026 Outlook And Overhauling Leadership Structure - simplywall.st
Deane Retirement Strategies Inc. Purchases Shares of 31,245 Zoetis Inc. $ZTS - MarketBeat
Assenagon Asset Management S.A. Lowers Position in Zoetis Inc. $ZTS - MarketBeat
ZOETIS INC : PIPER SANDLER CUTS TARGET PRICE TO $80 FROM $90 - Bitget
Zoetis Q2 Earnings Call Highlights - MarketBeat
Jacobs & Co. CA Lowers Stock Position in Zoetis Inc. $ZTS - MarketBeat
Maj Invest Holding A S Sells 78,471 Shares of Zoetis Inc. $ZTS - MarketBeat
Seilern Investment Management Ltd Has $33.06 Million Stock Position in Zoetis Inc. $ZTS - MarketBeat
Chemistry Wealth Management LLC Boosts Stake in Zoetis Inc. $ZTS - MarketBeat
Chesley Taft & Associates LLC Sells 17,131 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis (ZTS) Beat Q2 EPS Estimates, Is The Stock A Bargain? - simplywall.st
Zoetis Cut Its 2026 Guide in Q2 Earnings. The Dermatology Lead Is the Reason. - tikr.com
Rockland Trust Co. Boosts Stock Position in Zoetis Inc. $ZTS - MarketBeat
PensionDanmark Pensionsforsikringsaktieselskab Has $10.58 Million Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Community Trust & Investment Co. Lowers Stake in Zoetis Inc. $ZTS - MarketBeat
Zoetis (ZTS) Stock Sinks After Guidance Cut Deepens Profit Concerns - Sahm
Zoetis (NYSE:ZTS) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
From Freddie Mac to Zoetis: Burry’s Five Buys and Chip Short - Stocktwits
A Look at Zoetis Inc (ZTS) After 6.0% Decline -- GF Value $195.4 - GuruFocus
Zoetis Drops 5.4% After William Blair Downgrades to Market Perform - AlphaStreet
Zoetis Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zoetis nabs GE Health CFO for dual finance chief, COO role - CFO Dive
Zoetis (NYSE:ZTS) Stock Price Down 6.2% on Analyst Downgrade - MarketBeat
Zoetis Names Jay Saccaro to Combined Finance and Operations Role - Parsippany Focus
Zoetis (ZTS) Following Earnings And Guidance Cut With A Valuation Question - Yahoo Finance
Zoetis Combines Finance and Operations Under One Executive With Saccaro Appointment - centraljersey.com
Animal health company Zoetis appoints Saccaro as CFO and COO - ROI-NJ
Zoetis Inc. Stock Slips 6.0%, Underperforms Peers - Bitget
As Competition Crowds Zoetis, We Lower Our Fair Value Estimate - Morningstar
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):